Insider · CIK 0001336504

CLARK IAN T

Reports to the SEC for 14 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001336504

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-04	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,833 sh	$50.57	+$346K	17,155
2026-08-04	GHGuardant Health, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,833 sh	—	—	0
2026-08-04	GHGuardant Health, Inc.S Sale	Director	SSale	−5,092 sh	$158.80	−$809K	2,975
2026-08-04	GHGuardant Health, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,255 sh	—	—	0
2026-08-04	GHGuardant Health, Inc.S Sale	Director	SSale	−9,088 sh	$158.98	−$1.44M	8,067
2026-08-04	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,255 sh	$91.11	+$205K	10,322
2026-06-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2026-06-17	GHGuardant Health, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,092 sh	—	—	0
2026-06-17	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,092 sh	—	—	8,067
2026-06-17	GHGuardant Health, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,711 sh	—	—	2,711
2026-06-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-06-02	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+7,490 sh	—	—	14,490
2026-05-27	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.6K sh	—	—	20,582
2026-05-27	KYTXKyverna Therapeutics, Inc.A Award	Director	AAward	+5,093 sh	—	—	21,727
2026-05-20	GHGuardant Health, Inc.S Sale	Director	SSale	−6,876 sh	$106.90	−$735K	2,975
2025-12-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.1K sh	—	—	12,080
2025-12-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.5K sh	—	—	0
2025-12-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.5K sh	—	—	0
2025-12-19	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−41.8K sh	$30.48	−$1.28M	0
2025-12-19	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−193K sh	$29.71	−$5.74M	41,840
2025-12-19	OLMAOlema Pharmaceuticals, Inc.S Sale	Director	SSale	−29.9K sh	$28.83	−$862K	234,896
2025-12-19	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.1K sh	$4.08	+$49.2K	264,800
2025-12-19	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+21.5K sh	$7.84	+$169K	252,730
2025-12-19	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+21.5K sh	$3.61	+$77.7K	231,210
2025-12-19	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+210K sh	$4.41	+$924K	209,690
2025-12-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−210K sh	—	—	0
2025-12-05	GHGuardant Health, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,105 sh	—	—	0
2025-12-05	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,803 sh	$38.01	+$335K	27,759
2025-12-05	GHGuardant Health, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,803 sh	—	—	0
2025-12-05	GHGuardant Health, Inc.S Sale	Director	SSale	−17.1K sh	$107.27	−$1.83M	13,251
2025-12-05	GHGuardant Health, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.7K sh	—	—	0
2025-12-05	GHGuardant Health, Inc.S Sale	Director	SSale	−3,400 sh	$108.05	−$367K	9,851
2025-12-05	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,105 sh	$38.42	+$350K	18,956
2025-12-05	GHGuardant Health, Inc.S Sale	Director	SSale	−8,156 sh	$106.67	−$870K	30,306
2025-12-05	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.7K sh	$31.84	+$341K	38,462
2025-08-01	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+7,000 sh	—	—	7,000
2025-07-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$4.74	+$81.8K	100,150
2025-07-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	34,497
2025-06-18	GHGuardant Health, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,092 sh	—	—	5,092
2025-06-18	GHGuardant Health, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,833 sh	—	—	6,833
2025-06-17	GHGuardant Health, Inc.S Sale	Director	SSale	−6,672 sh	$48.38	−$323K	9,851
2025-06-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-12	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,088 sh	—	—	16,523
2025-06-12	GHGuardant Health, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,088 sh	—	—	0
2025-06-11	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.2K sh	—	—	24,150
2025-06-03	GDRXGoodRx Holdings, Inc.A Award	Director	AAward	+57.1K sh	—	—	82,902
2025-05-29	KYTXKyverna Therapeutics, Inc.A Award	Director	AAward	+16.6K sh	—	—	16,634
2025-05-29	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+65.4K sh	—	—	65,351
2024-11-12	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,076 sh	$4.18	+$4,497.68	16,753
2024-11-12	GHGuardant Health, Inc.S Sale	Director	SSale	−1,076 sh	$29.52	−$31.8K	15,677

Recent filings

Accepted (ET)
Aug 54
CLARK IAN T0001336504-26-000008
SEC(opens sec.gov)
Jun 234
CLARK IAN T0001336504-26-000006
SEC(opens sec.gov)
Jun 224
CLARK IAN T0001336504-26-000004
SEC(opens sec.gov)
Jun 154
CLARK IAN T0001610717-26-000222
SEC(opens sec.gov)
Jun 44
CLARK IAN T0001628280-26-040909
SEC(opens sec.gov)
May 294
CLARK IAN T0001193125-26-248435
SEC(opens sec.gov)
May 224
CLARK IAN T0001336504-26-000002
SEC(opens sec.gov)
Dec 234
CLARK IAN T0001336504-25-000009
SEC(opens sec.gov)

Companies

Address

3100 HANOVER STREET

PALO ALTO, CA, 94304